OmniAb, Inc.

NASDAQ:OABI

4.7 (USD) • At close July 24, 2024
Bedrijfsnaam OmniAb, Inc.
Symbool OABI
Munteenheid USD
Prijs 4.7
Beurswaarde 550,492,412
Dividendpercentage 0%
52-weken bereik 3.56 - 6.715
Industrie Biotechnology
Sector Healthcare
CEO Mr. Matthew W. Foehr
Website https://www.omniab.com

An error occurred while fetching data.

Over OmniAb, Inc.

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken,

Vergelijkbare Aandelen

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)